Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.
USD 9.95
Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.

Contact Information

Headquarters
Ruta Panamericana Km 38,5
Garin; Buenos Aires; Map
Postal Code: B1619IEA
Tel: +54 3327 448
Fax: +54 3327 448
Email: @biogenesisbago.com
Website: http://www.biogenesisbago.com

Full name: Biogenesis Bago S.A.

Previous name(s): Biogenesis S.A. (2005)
Vetia S.A. (2007)

Status: Non-Listed
Legal Form: Limited Liability Partnership
Operational Status: Operational
EMISid: 2033225
CUIT: 30628568835

Main Activities

Main Activities: Pharmaceutical and Medicine Manufacturing

Main Products

veterinary products

Company Description

Biogenesis-Bago is a company with regional-scope born from the merger of two leading companies in animal health and biotechnology in Argentina: Biogenesis and Instituto San Jorge Bago. Is a regional leader in animal health and the largest exporter of veterinary products in Argentina, since 1991.

More

Key Executives

President
More

Competitors - Argentina

N | USD | EUR

EMIS DealWatch Deals

DealMonitor Deal Intents

for 9.95 USD
Payment methods include:
USD 9.95
Payment methods include:
The full PDF report for this company will be available to download immediately after purchase. The report will contain:
Company Tear Sheet
Contact Information
NAICS Industry Classification
Business description
Basic Information
Share Price information
Key Executives
Ownership Details
Subsidiaries and Affiliates
Key Financial Highlights
Financial Performance Charts
Latest M&A and ECM Deals
Top Competitors
Financial Statements
Annual Statements
Ratios
EMIS Credit Analytics
EMIS Benchmark Score

- or -

EMIS company profiles are part of a larger information service that combines company, industry and country data and analysis for over 120 emerging markets on a unique information platform.

If you need broad and deep coverage of one or many countries, you may be interested in subscribing. Request a demonstration of our full service and one of our account managers will be in touch.

Register Your Interest